Lilly...es lo que se viene encima para el resto del 2011.

Eli Lilly described its strategy for surviving a reduction of $7 billion in revenue through 2014 with a simple, if depressing, graphic: A big, red, downward pointing arrow with the label “$1 billion.” Lilly CFO Derica Rice told analysts he intends to cut that much from the company’s expenses in 2011 order to maintain R&D spending:



Instead, it intends to chop away at its own workforce, cutting $1 billion in expenses this year. Most of those cuts will come in the form of layoffs, as this chart of Lilly’s historic layoff strategy — 7,500 total job losses so far — indicates:


Lilly wants those cost-savings to fund R&D, which it says will reach 25 percent of revenues. Lilly has come up with a cute nickname for this hellish period, “YZ.” After years YZ — now through 2014 — the company believes its late stage pipeline of new drugs will kick in, and all will be well. (Ver)

O será que tiene algo "entre manos...?